相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Brain malignancies: Glioblastoma and brain metastases
Tamara T. Lah et al.
SEMINARS IN CANCER BIOLOGY (2020)
Abemaciclib, a CDK4/6 inhibitor, exerts preclinical activity against aggressive germinal center-derived B-cell lymphomas
Yuka Tanaka et al.
CANCER SCIENCE (2020)
The Ongoing Search for Biomarkers of CDK4/6 Inhibitor Responsiveness in Breast Cancer
Scott F. Schoninger et al.
MOLECULAR CANCER THERAPEUTICS (2020)
Abemaciclib induces atypical cell death in cancer cells characterized by formation of cytoplasmic vacuoles derived from lysosomes
Hirotsugu Hino et al.
CANCER SCIENCE (2020)
Streptococcus gallolyticus abrogates anti-carcinogenic properties of tannic acid on low-passage colorectal carcinomas
Sonja Oehmcke-Hecht et al.
SCIENTIFIC REPORTS (2020)
CK2 inhibition with silmitasertib promotes methuosis-like cell death associated to catastrophic massive vacuolization of colorectal cancer cells
Eduardo Silva-Pavez et al.
CELL DEATH & DISEASE (2019)
Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer
Navid Sobhani et al.
CELLS (2019)
Study of the mechanism by which dinaciclib induces apoptosis and cell cycle arrest of lymphoma Raji cells through a CDK1-involved pathway
Huayan Zhao et al.
CANCER MEDICINE (2019)
The circular RNA circ-Ccnb1 dissociates Ccnb1/Cdk1 complex suppressing cell invasion and tumorigenesis
Ling Fang et al.
CANCER LETTERS (2019)
Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics
Artemiy S. Silantyev et al.
CELLS (2019)
Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015-2019)
Concepcion Sanchez-Martinez et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma
Peng Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Cyclin-dependent kinase 9 (CDK9) is a novel prognostic marker and therapeutic target in osteosarcoma
Hangzhan Ma et al.
EBIOMEDICINE (2019)
Oxidative Stress Induces Telomere Dysfunction and Senescence by Replication Fork Arrest
Elisa Coluzzi et al.
CELLS (2019)
Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer
Angela Chou et al.
GUT (2018)
Mitochondrial membrane potential
Ljubava D. Zorova et al.
ANALYTICAL BIOCHEMISTRY (2018)
Palbociclib synergizes with BRAF and MEK inhibitors in treatment naive melanoma but not after the development of BRAF inhibitor resistance
Claire A. Martin et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed Tumor Microenvironment and Enhances the Efficacy of PD-L1 Checkpoint Blockade
David A. Schaer et al.
CELL REPORTS (2018)
Integrated genomic analyses in PDX mode reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma
Cheng-Lung Hsu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Anti-tumor effect of CDK inhibitors on CDKN2A-defective squamous cell lung cancer cells
Eun-Hui Jeong et al.
CELLULAR ONCOLOGY (2018)
Microarray data of transcriptome shifts in blood cell subsets during S1P receptor modulator therapy
Dirk Koczan et al.
SCIENTIFIC DATA (2018)
Pan-CDK inhibition augments cisplatin lethality in nasopharyngeal carcinoma cell lines and xenograft models
Nicholas L. Syn et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2018)
Autophagy is essential for flavopiridol-induced cytotoxicity against MCF-7 breast cancer cells
Shuo Wang et al.
MOLECULAR MEDICINE REPORTS (2017)
Replication stress-induced endogenous DNA damage drives cellular senescence induced by a sub-lethal oxidative stress
Gireedhar Venkatachalam et al.
NUCLEIC ACIDS RESEARCH (2017)
CDK20 interacts with KEAP1 to activate NRF2 and promotes radiochemoresistance in lung cancer cells
Q. Wang et al.
ONCOGENE (2017)
CDK1 promotes nascent DNA synthesis and induces resistance of cancer cells to DNA-damaging therapeutic agents
Hongwei Liao et al.
ONCOTARGET (2017)
Preclinical characterization of abemaciclib in hormone receptor positive breast cancer
Raquel Torres-Guzman et al.
ONCOTARGET (2017)
Dinaciclib potently suppresses MCL-1 and selectively induces the cell death in human iPS cells without affecting the viability of cardiac tissue
Khaled Alsayegh et al.
SCIENTIFIC REPORTS (2017)
Deciphering molecular mechanisms of arginine deiminase-based therapy - Comparative response analysis in paired human primary and recurrent glioblastomas
Claudia Maletzki et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Inhibition of CDK-mediated Smad3 phosphorylation reduces the Pin1-Smad3 interaction and aggressiveness of triple negative breast cancer cells
Alexandra L. Thomas et al.
CELL CYCLE (2017)
Inhibition of Cdk5 induces cell death of tumor-initiating cells
Melanie M. Mandl et al.
BRITISH JOURNAL OF CANCER (2017)
Effect of abemaciclib (LY2835219) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo
Tong Wu et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Targeting CDK4 and CDK6: From Discovery to Therapy
Charles J. Sherr et al.
CANCER DISCOVERY (2016)
Mitochondrial generation of superoxide and hydrogen peroxide as the source of mitochondrial redox signaling
Martin D. Brand
FREE RADICAL BIOLOGY AND MEDICINE (2016)
CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer
Shawn F. Johnson et al.
CELL REPORTS (2016)
Dinaciclib, a Cyclin-Dependent Kinase Inhibitor Promotes Proteasomal Degradation of Mcl-1 and Enhances ABT-737-Mediated Cell Death in Malignant Human Glioma Cell Lines
Esther P. Jane et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
CDK1-Mediated SIRT3 Activation Enhances Mitochondrial Function and Tumor Radioresistance
Rui Liu et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Cyclin-Dependent Kinase 5 (CDK5) Controls Melanoma Cell Motility, Invasiveness, and Metastatic Spread-Identification of a Promising Novel therapeutic target
Savita Bisht et al.
TRANSLATIONAL ONCOLOGY (2015)
Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway
Ge Qin et al.
ONCOTARGET (2015)
Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft
Thomas J. Raub et al.
DRUG METABOLISM AND DISPOSITION (2015)
Methuosis Nonapoptotic Cell Death Associated with Vacuolization of Macropinosome and Endosome Compartments
William A. Maltese et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
PD-0332991 induces G1 arrest of colorectal carcinoma cells through inhibition of the cyclin-dependent kinase-6 and retinoblastoma protein axis
Chunsheng Li et al.
ONCOLOGY LETTERS (2014)
Host defense peptides for treatment of colorectal carcinoma - a comparative in vitro and in vivo analysis
Claudia Maletzki et al.
ONCOTARGET (2014)
Aurora A kinase (AURKA) in normal and pathological cell division
Anna S. Nikonova et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Establishment and Characterization of Primary Glioblastoma Cell Lines from Fresh and Frozen Material: A Detailed Comparison
Christina Susanne Mullins et al.
PLOS ONE (2013)
Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models
Georg Feldmann et al.
CANCER BIOLOGY & THERAPY (2011)
A chalcone-related small molecule that induces methuosis, a novel form of non-apoptotic cell death, in glioblastoma cells
Jean H. Overmeyer et al.
MOLECULAR CANCER (2011)
Hypoxia and mitochondrial oxidative metabolism
Giancarlo Solaini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2010)
Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor
David Parry et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Decrease of Plasminogen Activator Inhibitor-1 May Contribute to the Anti-Invasive Action of Cannabidiol on Human Lung Cancer Cells
Robert Ramer et al.
PHARMACEUTICAL RESEARCH (2010)
Conspirators in a Capital Crime: Co-deletion of p18INK4c and p16INK4a/p14ARF/p15INK4b in Glioblastoma Multiforme
David A. Solomon et al.
CANCER RESEARCH (2008)
HEI10 negatively regulates cell invasion by inhibiting cyclin B/Cdk1 and other promotility proteins
M. K. Singh et al.
ONCOGENE (2007)
INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions
Eduardo T. Canepa et al.
IUBMB LIFE (2007)
Rhodamine 123 as a probe of mitochondrial membrane potential:: evaluation of proton flux through F0 during ATP synthesis
A Baracca et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2003)
分享论文
